Quantessence Capital’s Abbott ABT Stock Holding History

Quantessence Capital’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,383	Closed	-$496K	–	334
2024 Q4	$496K	Buy	+4,383	New	+$507K	0.2%	116

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Quantessence Capital's ABT Position: Q1 2025 in Review

Quantessence Capital sold out of Abbott (ABT) in Q1 2025, closing a stake of 4,383 shares — an estimated $496K sold.

Quantessence Capital first reported a position in ABT in Q4 2024 and held it in 1 quarter. The position peaked at $496K in Q4 2024. 3,168 funds tracked by Wall St. Rank hold ABT as of Q1 2025.

Quantessence Capital reported no remaining Abbott position as of Q1 2025 after selling out during the quarter.
Quantessence Capital sold 4,383 Abbott shares in Q1 2025, an estimated $496K.
Quantessence Capital first reported a position in Abbott in Q4 2024 and held it in 1 quarter.
Quantessence Capital's Abbott position peaked at $496K in Q4 2024.
3,168 funds tracked by Wall St. Rank held Abbott as of Q1 2025.

Based on Quantessence Capital's 13F filing for Q1 2025, filed 15 May 2025.